Patna, Bihar | July 19, 2025: Buddha Cancer Centre, in association with Cancer Care & Cure Public Charitable Trust, successfully organized the Uro-Onco Summit 2025 at Hotel Chanakya, Patna. The academic summit, themed �Update on Uro-Malignancy�, brought together leading oncologists, urologists, and medical professionals to discuss recent advancements in the diagnosis and management of urological cancers.
The summit focused on emerging trends in genetic testing in prostate cancer, precision oncology, and the evolving role of technology in urological cancer care. With more than 130 delegates attending from across Bihar and neighboring regions, the event marked a significant step toward strengthening evidence-based and patient-centric cancer care in the state.
One of the key highlights of the Uro-Onco Summit 2025 was the emphasis on genetic testing for early diagnosis and risk stratification in prostate cancer. Experts discussed how molecular profiling and germline testing are transforming treatment decision-making, enabling more personalized and effective therapies for patients.
Sessions also explored the growing role of precision oncology, where treatment strategies are tailored based on individual tumor biology. The discussions highlighted how precision medicine can improve outcomes, reduce unnecessary toxicity, and enhance the overall quality of life for cancer patients.
The summit featured insightful discussions on the integration of artificial intelligence (AI) and robotic-assisted surgery in urological oncology. Speakers shared real-world experiences demonstrating how AI-driven diagnostics and minimally invasive robotic procedures are improving surgical accuracy, reducing recovery time, and enhancing patient safety.
These advancements, experts noted, represent a paradigm shift in urology, making high-quality cancer care more accessible and efficient.
The academic program was enriched by the presence of renowned faculty members, including:
The organizers expressed their sincere gratitude to all speakers for sharing their expertise, clinical insights, and practical experiences, which significantly enhanced the scientific value of the summit.
The event was honored by the presence of the Chief Guest, Shri Shashank Shekhar Sinha, CEO, Bihar State Health Society. Addressing the gathering, he appreciated the initiative taken by Buddha Cancer Centre and emphasized the importance of academic collaboration and innovation in strengthening cancer care services in Bihar.
The Uro-Onco Summit 2025 concluded with a shared commitment among participants to advance personalized, ethical, and accessible cancer care in the region. The organizers reaffirmed their dedication to continuous medical education, research-driven practice, and multidisciplinary collaboration for improving outcomes in urological cancers.
Buddha Cancer Centre continues to play a pivotal role in bringing high-quality academic platforms to Bihar, ensuring that healthcare professionals remain updated with global advancements in oncology.
The summit stood as a testament to the growing focus on innovation, education, and excellence in cancer care in the state.
